1.

纳入研究的一般情况

The characteristics of included studies

Included studies	Cases			Age (Years) (average*)			Sex (M/F)		Aidi injection (mL)	Time (day)	Outcome
	Aidi+TP	TP		Aidi+TP	TP		Aidi+TP	TP
①efficacy rate; ②quality of life; ③myelosuppression; ④gastrointestinal reaction; ⑤damage of liver and kidney; ⑥neurotoxicity; ⑦alopecia; ⑧immune function.
Bian GM[11]	34	30		(62.3*)	(61.8*)		23/11	21/9	50	56	①②③④⑤⑥⑦
Chen XM[12]	32	32		47-72 (64*)	49-71 (62*)		21/11	18/14	50	42	①②③④
Hou EC[13]	35	35		34-69 (52*)	37-70 (51*)		22/13	19/16	50	42	①②③④⑧
Li XD[14]	48	48		—	—		—	—	50	56	①②③
Lin Q[15]	30	30		35-72 (55*)	37-73 (57*)		21/9	20/10	50	28	①②③④
Peng RT[16]	32	32		42-75 (54.6*)	45-72 (53.7*)		22/10	20/12	50	42	①②③
Su W[17]	32	32		33-75 (55*)	34-75 (54*)		20/12	19/13	50	42	①②③④
Wang HM[18]	40	40		—	—		—	—	80-100	≥42	①②③④⑤
Yang G[19]	40	42		28-75	30-77		28/12	28/14	50-100	42	①②③④⑤⑥
Zhou H[20]	50	46		36-63 (56*)	35-65 (54*)		32/18	28/18	50	42	①③④⑤⑥⑦
Zhu QS[21]	30	30		36-74 (57*)	33-74 (59*)		15/15	17/13	50	63	①②③